Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
Recombinant human erythropoietin has been used for more than two decades in clinical practice with promising results in the treatment of anemia associated with chronic renal insufficiency and in patients with cancer. Recent evidence has uncovered new nonhematopoietic functions of this protein and ha...
Saved in:
Main Authors: | Rafael Alejandro Gómez Baute, Liermis Dita Salabert, Yaney González Yglesias, Tamara Guerra Alfonso, Maritza Cabrera Zamora |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2010-07-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/1158 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocardial Perfusion Scintigraphy in Ischemic Heart Disease
by: Sonia María Sánchez Valcarcel, et al.
Published: (2021-09-01) -
Neuroimaging: biochemical principles and its application in the cerebrovascular ischemic disease.
by: Zenaida Milagros Hernández Díaz, et al.
Published: (2009-07-01) -
Escolha de Dupla Antiagregação na Doença Arterial Coronariana: Apenas uma Questão de Equilíbrio entre a Carga Isquêmica e o Risco de Sangramento?
by: Maria Cristina Almeida, et al.
Published: (2025-01-01) -
Complications and Mortality Characterization in Acute Ischemic Cerebrovascular Disease
by: Ricardo Leyva Tornés, et al.
Published: (2021-09-01) -
Ischemic Heart Disease and Work Disability in Patients Treated at the Internal Medicine Consultation and Assessed by the Expert Medical Labor Commission
by: Belkis Vicente Sánchez, et al.
Published: (2016-02-01)